Fatty acids are important energy donors for the healthy heart. These substrates are supplied to the myocardium bound to albumin to overcome their low solubility in aqueous solutions such as blood plasma. Transport from the microvasular compartment to the mitochondria inside the cardiomyocytes is most likely a combination of passive and protein-mediated diffusion. Alterations in tissue content of fatty acid-transport proteins may contribute to myocardial diseases such as the diabetic heart, and cardiac hypertrophy and failure.
Introduction
passive diffusion, a variety of proteins are involved in the transfer of fatty acids from the cardiac microvascular Under normal physiological conditions long-chain fatty compartment to the intracellular sites of conversion [5] [6] [7] [8] [9] . acids are important oxidizable substrates for the heart, In particular, plasmalemmal fatty acid-binding protein serve as building blocks of cellular membranes after their (FABP ), fatty acid translocase (FAT / CD36), and / or pm esterification into phospholipids and are involved in signal fatty acid transport protein (FATP) may play dominant transducing pathways [1, 2] . Because of their low solubility roles in transmembrane trafficking of fatty acids. A in water, fatty acids are supplied to the heart either cytoplasmic fatty acid binding protein (heart-type FABP) attached to plasma albumin or covalently bound in the is thought to be instrumental in maintaining sufficient flux triacylglycerol core of circulating lipoproteins. After dislevels of fatty acids from the sarcolemma to the mitosociation of the albumin-fatty acid complex or hydrolysis chondrial or sarcoplasmic membrane. of the triacylglycerols, fatty acids are transferred from the The notion that proteins are most likely involved in the capillary lumen through the capillary endothelium and uptake and intracardiac transport of fatty acids has prompinterstitial compartment to the cardiac muscle cell [3, 4] .
ted research exploring the regulation of the expression of Subsequently, fatty acids cross the sarcolemma and cytogenes encoding for these fatty acid handling proteins. In plasm to be converted into fatty acyl-CoA at the mitoparticular, the role of fatty acids themselves and their chondrial outer membrane or the sarcoplasmic reticulum.
derivatives in gene expression in the heart is becoming In a carnitine mediated process the bulk of these fatty acid subject of intensive studies [2, 10] . Moreover, if cardiac derivatives pass the mitochondrial inner membrane and are fatty acid uptake and transport are mediated by specific degraded in the b-oxidation pathway and citric acid cycle.
proteins, it is conceivable that various inherited or acquired The remaining part of the acyl moieties of fatty acyl-CoA cardiac myopathies are causally related to defects in the is incorporated into the esterified lipid pool, mainly synthesis of these proteins, occurring either at the tranconsisting of phospholipids and triacylglycerols [1] .
scriptional or translational level. Recent observations indiRecent findings strongly suggest that in addition to cate that some cardiomyopathies are indeed associated with impaired expression of proteins putatively involved in the intracardiac fatty acid transfer process [11, 12] .
In this survey we will, in a concise manner, reiterate the serve as precursor of biologically active eicosanoids, significance of fatty acids for cardiac energy conversion, produced in cardiac endothelial cells and to a minor extent and their possible route(s) of transport from the mialso in cardiac muscle cells [22] [23] [24] . crovascular compartment into the interior of the cardiac A variety of studies on cardiac energy metabolism has myocyte. Further, the mechanisms underlying intracardiac shown that at physiological workloads the amount of fatty fatty acid transport and the potential regulatory role of acids oxidized is on the order of 50-100 nmol / min per fatty acid handling proteins and the regulation of their gram wet weight [1] . Thus, as discussed above, in steadyexpression by fatty acids themselves will be reviewed.
state conditions a similar amount of fatty acyl moieties Finally, the consequences of alterations in the expression must be transferred from the microvascular compartment of proteins putatively involved in fatty acid uptake and to the cardiac parenchymal cells, i.e., the cardiomyocytes. transport, as seen in selected pathophysiological states, will Blood-borne fatty acids are delivered to the heart basically be briefly discussed.
in two different forms (Fig. 1) . The first source is plasma albumin carrying fatty acids, which are originally released from fat cells. Second, circulating lipoproteins, such as 2. Cardiac need of fatty acids very low density lipoproteins (VLDL) and chylomicrons, originating from liver and gut, respectively, contain apSince the pioneering studies of Bing et al. [13] it has preciable amounts of triacylglycerols, the fatty acyl moibeen fully appreciated that fatty acids are important eties of which can be set free by lipoprotein lipase [25, 26] . substrates for myocardial energy conversion. Under normal This enzyme is produced in the cardiac muscle cell and physiological conditions about 60-70% of the total amount transported to the endothelium, where it becomes attached of ATP required for adequate contraction of the heart is to the luminal side of the endothelial cell ( Fig. 1 ). Due to generated by mitochondrial oxidation of fatty acids [1] .
technical limitations, the quantitative contribution of circuThe remaining part is mainly accounted for by oxidation of lating triacylglycerols to cardiac fatty acid utilization in carbohydrates, such as glucose and lactate [14] [15] [16] .
situ has not yet been precisely determined, but is considMyocardial tissue contains substantial amounts of fatty ered to be moderate [27] . Recently, Wang et al. [28] acyl moieties. The bulk is incorporated in the membrane estimated the contribution of lipoprotein triacylglycerol phospholipid pool and, hence, should be considered as fatty acids to total fatty acid utilization in the isolated rat structural fatty acids. On the average about 40 mmol fatty heart to be 20-25% at maximum. Studies in which arterioacyl moieties per gram wet weight of tissue is present in this distinct lipid pool. Although exchange of phospholipid-incorporated fatty acids with the cellular unesterified fatty acid pool readily occurs, the phospholipidfatty acyl pool is quantitatively not important as storage form of oxidizable fatty acids since a substantial decline or major fluctuations of the size of the membrane phospholipid pool is most likely not compatible with life [1] . Myocardial triacylglycerol contains about 4 mmol fatty acyl moieties per gram of tissue, stored in lipid droplets in the cytoplasm of the cardiac muscle cells in the close vicinity of the mitochondrial outer membrane [17] . Under steady state conditions no major alterations in the absolute amount of triacylglycerol fatty acids take place. The level of fatty acids in the unesterified form in cardiac tissue is extremely low, i.e., on the order of 30 to 60 nmol fatty acids per gram of tissue [18] . These considerations lead to the conclusion that in normal physiological circumstances, cardiac muscle cells rely heavily on an adequate and unimpeded supply of blood-borne fatty acids to fulfil their energy requirements.
In addition to supplying energy, fatty acids may take part in intracellular signal transduction [10, 19] . Recent transport in the heart, highlighting potential membrane barriers such as the endothelium and sarcolemma. local venous differences of albumin-bound fatty acids were transendothelial transfer rate of albumin, either by transmeasured, indicate that the latter source of plasma-borne cytosis (Fig. 2, route 1) or diffusion through the interfatty acyl moieties significantly contributes to overall endothelial clefts (Fig. 2 , route 2), is far too low to account myocardial lipid oxidation [1] . Therefore, in the present for a transendothelial influx of fatty acids of about 50-100 overview we will mainly focus on cardiac uptake and nmol / min per gram [3, 4] , although some albumin will transport of albumin-derived fatty acids.
escape from the intravascular compartment to compensate for loss of interstitial albumin via lymphatic flow. The movement of albumin-fatty acid complexes through the 3. Intracardiac transport routes of fatty acids endothelial clefts is particularly hampered by the size of the albumin molecule and by tethering of the glycocalyx The notion that fatty acids are supplied to cardiac lining the endothelial cells [3, 4] . The corollary to this muscle cells from the capillary lumen implies that on their notion is that fatty acids should be released from albumin way from this compartment to the intracellular site of prior to transfer across the endothelial barrier. Nonconversion potential barriers have to be crossed by these protein-bound fatty acids might pass the endothelial layer hydrophobic compounds. The first constraint encountered either via the interendothelial clefts or through the endoby fatty acids translocating from the microvascular comthelial cells composing the microvascular wall. Experimenpartment to the cardiac parenchymal cells is the endotal evidence and theoretical considerations indicate, howthelium ( Fig. 1) . Theoretically, fatty acids can cross the ever, that diffusion of fatty acids through interendothelial endothelial barrier either complexed to the fatty acid clefts is inconsequential for bulk transport to the cardiac carrier albumin or as free, non-protein-bound fatty acyl muscle cells and, hence, that fatty acids traffic through the moieties. The first option is rather unlikely since the microvascular endothelial cells [3, 4, 29] . Fatty acids might cross the endothelial cells by peridebate [8, [32] [33] [34] . Two opposing views emerge from endothelial diffusion [30] . This would be accomplished by experimental studies performed in the last decade. On the dissolution of fatty acids in the endothelial luminal surface one hand, it is proposed that trafficking of fatty acids membrane followed by movement of the fatty acids by across a biological membrane is accomplished by simple diffusion within the plasmalemma down a concentration diffusion, governed by the physicochemical properties of gradient to the abluminal surface membrane (Fig. 2, route water, the phospholipid bilayer of the membrane, and fatty 3.1). This hypothetical route has been dismissed by acids [32, 33, 35] . On the other hand, fatty acids are Bassingthwaighte et al. [3] on the basis of calculations assumed to traverse a biological membrane by facilitated rather than experimental findings. Their calculations premechanisms involving specific membrane-associated fatty dict that peri-endothelial transfer of fatty acids would acid-binding and carrying proteins [8, 36, 37] . require a very high concentration gradient within the Proponents of the physicochemical mechanism base endothelial cell membrane. To accomplish such a gradient their view on findings mainly obtained in preparations of the fatty acid content in the luminal surface membrane artificial membranes [38, 39] . These experiments show that should surpass the phospholipid content. This condition absorption of fatty acids from an aqueous environment to was thought not to be compatible with the normal chemical the outer leaflet of a vesicle, composed of pure phoscomposition and physiological function of a biological pholipids, is fast. Translocation of fatty acids from the membrane [3] . Therefore, fatty acids most likely pass the outer leaflet to the inner leaflet of the vesicles via a endothelium by transport across the luminal membrane, flip-flop mechanism takes a few milliseconds. The desorpthrough the cytoplasm, and then across the abluminal tion of the fatty acyl moieties from the outer leaflet into the membrane of the endothelial cell (Fig. 2 , route 3.2 and 4).
second aqueous compartment is also reported to be a fast After reaching the second barrier, the interstitial compartprocess [32] . Recent findings strongly suggest that fatty ment separating endothelial and cardiac muscle cells, the acids traverse the vesicular phospholipid bilayer mainly in fatty acid molecules bind to interstitial albumin and are the unionized form, indicating that transmembrane diffutransferred to the cardiomyocytes by this carrier protein.
sion of fatty acids is proton-mediated [33] . Due to the The third barrier is represented by the sarcolemma, enclosphysicochemical properties of the anionic phospholipids in ing the cardiac muscle cell. Subsequently, the bulk of fatty the membrane the pK value of fatty acids dissolved in the a acids taken up by the cardiomyocytes crosses the fourth phospholipid bilayer is about 7.5, a value close to the barrier, the cytoplasm, to reach the sarcoplasmic reticulum physiological pH of blood and interstitial fluid. This notion or mitochondrial outer membrane.
implies that approximately 50% of fatty acids dissolved in the outer leaflet of a biological membrane is present in the protonated form, which substantially facilitates bulk diffu-4. General aspects of fatty acid transport through sion of fatty acids from the outer to the inner membrane aqueous compartments and phospholipid bilayers leaflet. Moreover, recent observations of Trigatti and Gerber [40] in isolated 3T3-L1 adipocytes indicated that As can be inferred from the above, potential barriers for acidification of the cytoplasm significantly reduced the intra-organ transport of fatty acids are aqueous comparttransfer of fatty acids from the surrounding medium into ments and biological membranes. Although the diffusion the cell interior. Since the latter effect could not be related rate of fatty acids in an aqueous environment is relatively to alterations in the cellular rate of fatty acid metabolism, high, their low solubility in aqueous solutions implies that the authors concluded that their findings are in line with only minute amounts of fatty acids are translocated in this the notion that transmembrane movement of fatty acids manner. Therefore, carrier proteins are required to transoccurs by simple diffusion of protonated fatty acids across port physiologically relevant amounts of hydrophobic fatty a lipid bilayer. acids in an aqueous environment. In the vascular and Some uncertainty exists, however, with respect to the interstitial compartments this requirement is met by plasma rate of delivery of fatty acids to a (biological) membrane. albumin, present in a relatively high concentration (on the Since it is generally acknowledged that fatty acids are order of 0.6 and 0.3 mM in the vascular and interstitial supplied to a plasma membrane complexed to albumin, the compartments, respectively). The same holds for the rate of dissociation of fatty acid-albumin should be taken cytoplasm of the majority of parenchymal cells, where the into account when considering the overall fatty acid flux. abundant presence of low-molecular-mass FABPs is supZakim [32] suggested that in the liver the relative slowness posed to guarantee physiologically relevant flux levels of of the rate of dissociation of fatty acids from the carrier 21 fatty acids from the plasmalemma to intracellular sites of albumin (k 5 0.036 s ) does not limit the rate of uptake conversion [31] .
by the hepatocytes. It is, however, uncertain whether this Although general agreement exists on the transport conclusion does also hold for cardiac tissue. mechanism of fatty acids in aqueous compartments, the Proponents of the protein-mediated transmembrane precise mechanism underlying transmembrane movement transport mechanism base their theory on the discovery of of the lipophilic fatty acids is a matter of continuous membrane-associated proteins able to bind fatty acids or at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from fatty acid analogues. At present, a set of at least three exhibiting elevated uptake of a fluorescent fatty acid distinct proteins putatively involved in transmembrane analogue. This putative transporter, named fatty acid transport has been identified in various biological memtransport protein (FATP), has a molecular mass of 63 kDa branes (Table 1) . Stremmel et al. were the first to identify and is an integral membrane protein with multiple transin the hepatocyte plasma membrane a 40-43 kDa protein membrane sequences [50, 51] . FATP is found in most that displays a high affinity for fatty acids [41] . This mammalian tissues investigated [47, 50] . Interestingly, in peripherally bound protein, designated plasmalemmal fatty 1987 Fujii et al. [52] reported the purification of a 60 kDa acid-binding protein (FABP ), is found in several other high affinity fatty acid receptor from heart and kidney pm tissues including cardiac endothelium and cardiac muscle, membranes. This protein has not been further characterand appears closely related, if not identical to mitochonized, but on the basis of molecular size and in vitro drial aspartate aminotransferase (mAAT) [42] . Functional properties, may be identical to the later identified FATP. evidence for the involvement of FABP in cellular fatty pm acid uptake stems from studies showing that antibodies against this protein inhibit cellular fatty acid uptake [43] 5. Mechanisms of intracardiac fatty acid transport and that transfection of 3T3-L1 fibroblasts with a cDNA for FABP confers a saturable and 10-fold increased rate 5.1. Transendothelial transport of fatty acids pm of fatty acid uptake into these cells [44] . By labeling with fatty acid analogues, Abumrad et al.
Since diffusion of fatty acids through the interendotheli- [45] found in rat adipocytes an 88 kDa integral membrane al clefts or through the plasmalemmal membrane of the protein, called fatty acid translocase (FAT), which most endothelial cells each are quantitatively inconsequential [3] likely is a species homologue of the human leukocycte (Fig. 2 , routes 2 and 3.1), fatty acids first must cross the differentation antigen CD36. The highly glycosylated luminal membrane of the cardiac endothelial cell. The FAT / CD36 presumably has one or two membrane spanmechanism underlying cardiac transendothelial transfer of ning regions [46] and is expressed in a number of tissues, fatty acids has been extensively studied in isolated rabbit including the heart, but absent in liver [45, 47] . FAT / CD36
hearts with the use of radiolabeled albumin and palmitate mRNA increases during differentiation of preadipocytes [3, 4] . The experimental findings indicate that the influx of into adipocytes and this induction is paralleled by an fatty acids, delivered to the membrane in a non-protein increase in fatty acid transport into the cell [45, 48] .
bound form, from the microvascular compartment into the Moreover, transfection of FAT / CD36 cDNA into fibrocardiac endothelium is on the order of 50 pmol / min per blasts lacking the protein led to induction of a saturable, gram [3, 4] , taking into account that the non-protein-bound high-affinity component of oleate uptake [49] .
concentration of fatty acids in plasma is¯5 nM [53] . This More recently, Schaffer and Lodish [50] discovered influx is three orders of magnitude lower than the amount another candidate protein for facilitating the transmemof fatty acids extracted by the heart under normal physiobrane transport of fatty acids. This candidate protein was logical circumstances, i.e., 50-100 nmol / min per gram identified via expression cloning of an adipocyte cDNA [1] . This conclusion entails that instead of the non-protein library in COS7 cells and subsequent screening for cells bound fatty acid fraction in plasma, albumin-bound fatty [79] acids are of physiological relevance as driving force for specific, peripheral membrane fatty acid binding protein transendothelial transport.
(FABP ) is required for transition of fatty acids from the pm Exploring this issue in more detail, is was found that the microvascular compartment into the luminal endothelial transcapillary transfer of fatty acids is saturable with membrane, since antibodies directed against this protein increasing albumin concentrations. However, the capacity substantially decreased the unidirectional influx of fatty to transport fatty acids across the capillary wall at a fixed acids. In addition to the 40 kDa FABP , other membrane pm albumin concentration was found to be linearily related to proteins putatively involved in transport of fatty acids the total amount of fatty acids complexed to albumin, across the endothelial barrier, such as FAT / CD36 and without any sign of saturation up to 2.0 mM fatty acid [4] .
FATP, have been shown to be present in cardiac endotheliAlthough the experimental findings suggest that plasma al cells [47, 60] . The exact function of these proteins and fatty acids are directly translocated from the plasma fatty their contribution to overall transendothelial fatty acid acid carrier, albumin, to the luminal membrane of the transport remain, however, to be established. capillary endothelium, it is incompletely understood how After desorption from the inner leaflet of the luminal under physiological conditions the transfer of fatty acids to membrane fatty acids should permeate the aqueous cytocardiac endothelial cell membrane is accomplished. Direct plasm of the endothelial cell to reach the abluminal transfer of fatty acids from albumin to the luminal endomembrane [3] . Earlier reports from our laboratory indithelial membrane implies physical contact between the cated that the transfer of the poorly water soluble fatty albumin molecule and the membrane (Fig. 2, route 4) . The acids across the endothelial cytoplasm does not require a observation that unidirectional influx of fatty acids becarrier protein [1] . This conclusion was based on the comes saturated at elevated albumin concentrations sugnotion that, due to the short diffusion distance between the gests that a limited number of interaction sites for albumin endothelial luminal and abluminal membrane, bulk transwith the luminal endothelial membrane is available. These port of fatty acids might occur by passive diffusion in spite findings do not allow for discrimination between interof their low solubility in water (Fig. 2, route 3. 2). This action of albumin with either (domains of) phospholipids idea was further supported by the failure to identify of the outer membrane leaflet or with specific proteins significant quantities of a soluble fatty acid-binding protein attached to or localized within the phospholipid bilayer. If in homogenates of stable endothelial cell lines, derived proteins are involved, likely candidates are a family of from the adult rat heart [61, 62] . However, recent computer recently identified membrane proteins, capable of binding simulations and histochemical analysis of intact rat and albumin with a relatively high affinity [54] [55] [56] . At present, mouse hearts have shed new light on this issue. The model the physiological function of these proteins is supposed to studies predicted the need of a protein with a high affinity be the trapping of plasma albumin prior to endothelial for fatty acids in the endothelial cytoplasm required to transcytosis of the albumin molecule. However, a potential facilitate desorption of the fatty acid molecules from thé role of albumin binding proteins in the transfer of fatty inner leaflet of the luminal membrane [63] . Massouye et al. acids from the fatty acid carrier albumin into the luminal
[64] provided histochemical evidence for the presence of membrane of the cardiac endothelial cells is worth to small quantities of an epithelial-type fatty acid binding consider.
protein in human cardiac endothelial cells, making this Irrespective of the identity of the membrane components protein a likely candidate for transcytosolic transfer of involved in albumin-membrane interaction, the physical fatty acids in the cardiac endothelium. Recently, the contact between the carrier protein and the cardiac endopresence of heart-type FABP was immunohistochemically thelial membrane should result in a substantial acceleration established in the microvascular endothelium of the intact of the release rate of fatty acids from their albumin binding mouse heart [65] . Obviously, more detailed experiments sites. Scheider [57] and Svenson et al. [58] previously are required to solve the question as to whether and, if so, reported dissociation rates on the order of 15 to 20 s, and to what extent soluble fatty acid binding proteins are Zakim [32] over 25 s, which are far too low to accommorequired for transendothelial fatty acid transport. date physiological flux levels of fatty acids across the Movement of fatty acids from the cytoplasm across the cardiac endothelium, considering an average dwell time of abluminal endothelial membrane into the interstitial comblood in the cardiac microvascular compartment of 1 to 2 s partment may take place in a mirror-like fashion as [3] and a single pass extraction of fatty acids of 40-60% described above for the luminal membrane. After albumin- [1] . This situation is therefore basically different from that facilitated diffusion from the abluminal membrane of the in liver, where the extraction ratio of plasma fatty acids is endothelium to the cardiomyocytes, fatty acids again have generally lower [32] .
to be released from the albumin carrier prior to transAlthough passive diffusion as possible mechanism of sarcolemmal trafficking (Fig. 2) . fatty acid transport across the luminal endothelial membrane cannot be ruled out entirely [32, 33] , recent findings 5.2. Sarcolemmal transport of fatty acids suggest that membrane-associated proteins are implicated in transendothelial trafficking of fatty acids in the heart.
The last membrane barrier to be taken by fatty acids on Goresky et al. [59] observed that in the isolated rat heart a their way to intracellular conversion into acyl-CoA is the plasmalemma of the cardiac muscle cell. The mechanisms universal inhibitor of membrane-associated transport proby which fatty acids are translocated across the sarcolemteins, or sulfo-N-succinimidyl oleate (SSO), a ligand of the ma are most likely identical to those for endothelial fatty acid transporter, FAT / CD36 [66, 67] , suggesting the membranes. Also in this case, the two extremes are a involvement of membrane proteins in fatty acid uptake by simple physicochemical process based on passive diffusion cardiac muscle cells. of the fatty acid molecule and the passage through the The studies of Luiken et al. [66] also confirm that fatty membrane barrier by means of (a set of) membraneacid uptake by cardiac myocytes is most likely driven by associated proteins (Table 1) . their rapid intracellular metabolic conversion, and that this The possible involvement of sarcolemmal proteins in the close link between uptake and metabolism hampers the uptake of fatty acids by cardiac myocytes was recently elucidation of the precise cellular uptake mechanism. explored by Luiken et al. [66] . They observed in isolated However, in subsequent studies, Luiken et al. [68] used adult rat cardiomyocytes saturation of palmitate uptake giant sarcolemmal vesicles prepared from rat heart to study when the concentration of palmitate (complexed to alfatty acid uptake in the absence of metabolism. These bumin with a constant ratio) in the incubation medium was vesicles, devoid of fatty acid metabolizing enzymes, raised from 10 to 300 mM. Interpretation of these findings contain cytoplasmic FABP which acts as intravesicular is, however, not unambiguous. It might indicate either sink for fatty acids. Similar to the studies with cardiac saturation of intracellular consumption of fatty acids or myocytes, palmitate uptake by sarcolemmal vesicles desaturation of membrane-associated fatty acid transfer prorived from these cells could be inhibited for up to 80% in teins. Interestingly, mild pre-treatment of isolated carthe presence of protein-modifying agents (trypsin, diomyocytes with low concentrations of trypsin, a wellphloretin), of antibodies against FABP or of highly pm known proteolytic enzyme, significantly depressed the rate reactive fatty acid derivatives such as SSO [68] . The of cardiac palmitate uptake, while leaving the cellular observation that none of these agents, either alone or in integrity intact (Fig. 3) . Moreover, palmitate uptake by combination, can fully inhibit palmitate transfer through isolated rat cardiac myocytes was found to be substantially the isolated sarcolemma suggests that for cardiac myocytes blocked by treatment of the cells with either phloretin, an there is a non-inhibitable component contributing to about 20% of cellular fatty acid uptake. The latter uptake is likely due to passive diffusion. Interestingly, the inhibitory actions of anti-FABP pm antibodies and SSO were non-additive [68] , suggesting that FABP and FAT / CD36 (and / or FATP) may cooperpm ate to translocate fatty acids across the sarcolemma. This raises the attractive hypothesis that the peripheral membrane protein FABP located at the extracellular leaflet pm could act as a trapping protein for fatty acids in order to facilitate fatty acid adsorption while the integral membrane protein(s) FAT / CD36 (and / or FATP) would function as a fatty acid translocase.
In other studies, Bonen et al. [69] observed that sarcolemmal vesicles prepared from skeletal muscles that are electrically stimulated for 25 min display a markedly higher rate of fatty acid uptake than vesicles from nonstimulated control muscles, and that this increase was paralleled by a higher sarcolemmal content of FAT / CD36, but not FABP , in vesicles prepared from stimulated pm muscles. Since the duration of the period of muscle contraction is too short for de novo protein synthesis, this increase in sarcolemmal FAT / CD36 most likely is due to protein translocation. Such a mechanism may show analogy to the short-term regulation of glucose uptake into muscle by insulin, which is due to translocation of GLUT4 from intracellular stores to the plasma membrane. How- of uptake by cardiac myocytes. The degree of acyl chain high-affinity fatty acid-binding site per protein molecule unsaturation is an important parameter determining the [9, 74, 75] . H-FABP is abundantly expressed in the cytoaqueous solubility of the fatty acid, and was found to play plasm of cardiac myocytes, and in rat heart H-FABP a significant role in the equilibrium between fatty acid accounts for approximately 3% of the cytoplasmic proteins association with specific proteins [53, 70] and with bio-(50 nmol / g wet weight) [76] . Immunoelectronmicroscopic logical membranes [33] . Despite these differences, the studies revealed its presence primarily in the soluble affinities of the various proteins and cell membranes for cytoplasm [9] , although minute amounts of H-FABP are fatty acids are such that, under normal conditions, the found inside the nucleus and in the mitochondrial matrix unbound fatty acid concentrations are extremely low [53] [77]. H-FABP is also expressed in skeletal muscles, and a and will hardly elicit a possible selective uptake of fatty positive relation is found between the H-FABP content and acid types. Possible differences in binding specificities of the oxidative capacities of muscles tissues (heart.red the sarcolemmal proteins (putatively) involved in fatty acid muscles.white muscles) [76, 78] , suggesting a functional uptake, to our knowledge, have only been explored by involvement of H-FABP in muscle lipid metabolism. An Baillie et al. [71] , who studied the in vitro properties of acyl-CoA binding protein (ACBP) of 10 kDa, which most FAT / CD36 isolated from rat adipocytes to find comparlikely binds the fatty acid after activation to its acyl-CoA able binding affinities for palmitate, oleate, stearate, thioester has also been detected in the cardiomyocyte [79] linoleate and arachidonate. It remains to be established (Table 1) . whether the other membrane proteins would favor the The physiological significance of cytoplasmic H-FABP uptake of selected fatty acid types.
in cardiac fatty acid handling was recently firmly estabCollectively, these recent observations point to the lished by Binas et al. [80] and Schaap et al. [81] . They involvement of sarcolemmal proteins in fatty acid handling studied fatty acid uptake by the heart of intact mice, of cardiac muscle cells. To cross the bridge between the carrying a targeted disruption of the gene coding for two extreme views of either non-protein-mediated or H-FABP, and utilization of fatty acids by cardiomyocytes protein-mediated fatty acid transport, we like to suggest isolated from these animals, respectively. Cardiac mRNA that both processes occur in parallel with their relative levels of several genes involved in plasmalemmal fatty contribution to total fatty acid uptake depending on the acid transport and intracellular metabolism were comparphysiological condition. Transport of protonated fatty acyl able in H-FABP knock-out and wild-type mice. Moreover, moieties may occur by rapid flip-flop across the phosno compensatory expression of other FABP types was pholipid bilayer, whereas proteins are involved in the detected in heart tissue. Cardiomyocytes isolated from transport of ionized fatty acyl moieties through the mem-H-FABP knock-out mice showed a markedly lowered brane barrier, enhancing the total capacity of the cell to uptake rate of palmitate (¯250%), while the uptake of utilize fatty acids supplied from the extracellular environoctanoate was not affected. In addition, palmitate oxidation ment. The protein-mediated mechanism might be of great by isolated cardiac myocytes from knock-out mice was importance during elevated metabolic activity (high workalso significantly depressed despite the fact that the load) when the content of protonated fatty acids inside the capacity for fatty acid oxidation, as measured in heart cell most likely increases due to enhanced generation of homogenates, was similar in H-FABP knock-out and wildprotons by glycolytic and mitochondrial activity. The type mice [81] . These observations give the first concluintracellular increase of protonated fatty acids may counsive evidence for a role of H-FABP in fatty acid uptake teract the diffusion of protonated fatty acids from the and oxidation in cardiac muscle cells. interstitium to the cytoplasmic compartment. This adverse As pointed out earlier FABP most likely facilitates bulk effect may be compensated for by protein-mediated transdiffusion of fatty acids in the sarcoplasm by enhancing port of ionized fatty acids from the interstitial compartment substantially the solubility of fatty acids in this aqueous into the cardiac muscle cell interior.
environment. Despite the fact that the diffusion rate of the fatty acid-FABP complex is slower than that of non-5.3. Transsarcoplasmic transport of fatty acids protein bound fatty acids, the overall diffusion capacity is enhanced approximately 20-fold [73] . Moreover, cytoplasMathematical models as well as in vitro studies have mic FABP may interact with the membrane-bound FAT / indicated that intracellular fatty acid carriers would be CD36 to facilitate the transfer of fatty acids from the indispensable for adequate transport of fatty acids from the sarcolemma into the cell interior [82] . This finding implies sarcolemma to the mitochondria interspersed between the that a continuum of proteins and protein interactions might myofibrils [72, 73] . In this respect, it is generally accepted be involved in guiding fatty acids from the vascular that cytoplasmic heart-type FABP (H-FABP) functions as compartment to the intracellular site of metabolic converintracellular fatty acid carrier inside the myocytes. Hsion. This notion is supported by the fact that computer FABP belongs to a family of 14-15 kDa lipid binding models predict that FABP is required for desorption of proteins, currently consisting of 13 members and also fatty acids from the inner leaflet of the sarcolemma into the including cellular retinoid-binding proteins, and shows one cytoplasm [63] . Direct delivery of the fatty acid molecule to the active centre of acyl-CoA synthetase may be also thelium [60] . The functional consequences of elevated facilitated by the fatty acid carrier FABP.
FAT / CD36 in this animal species are, however, less clear, 125 Studies by Richieri et al. [70] revealed that in vitro since uptake of the radiolabeled fatty acid analogue I-H-FABP will bind various fatty acid types (palmitate, BMIPP in the murine diabetic heart was found to be oleate, stearate, linoleate, and arachidonate) with compardepressed [100] . Contrasting data were also reported in able affinity, suggesting that there is no selective intracelhuman diabetes. Both in non-insulin dependent (NIDDM) lular trafficking of fatty acid types by H-FABP.
and insulin dependent (IDDM) patients cardiac oxidation 123 of I-heptadecanoic acid was not significantly different from healthy control subjects [101] . Strikingly, in subjects 6. Fatty acid handling proteins and cardiac with impaired glucose tolerance, without overt signs of 123 abnormalities NIDDM or IDDM, the myocardial I-heptadecanoic acid oxidation rate was significantly decreased [101] . Another The discussion as to whether cardiac uptake and transremarkable difference between diabetic rats and diabetic port of fatty acids are protein-mediated or not might have humans may concern the concentration of circulating fatty important clinical ramifications, since proteins are subject acids. In the streptozotocin-treated rat plasma fatty acid to alterations in production rates due to up-or downregulalevels are consistently increased [99] . In diabetic patients, tion of transcriptional and translational activity, and posthowever, some investigators failed to disclose a significant translational modifications such as phosphorylation. As a difference in plasma fatty acid levels between patients and consequence, altered levels and / or activities of fatty acid healthy controls [102] . handling proteins may give rise to cardiac abnormalities.
Collectively, the present findings indicate that the direcThe reverse may also be true, namely that pathological tion of changes in cardiac fatty acid utilization in the changes in myocardial performance will result in alteradiabetic heart, if any, is species and / or experimental model tions in level and / or activity of fatty acid handling proteins dependent. Moreover, it remains to be explored whether in in cardiac cells. During the past decade information is diabetes mellitus alterations in myocardial fatty acid becoming available suggesting that cardiac utilization and in the tissue content of proteins (putatively) pathophysiologic conditions such as diabetes, cardiac involved in fatty acid uptake and transport, if any, are hypertrophy and failure, and other types of carcausally related to the diseased state of the heart. diomyopathies, are associated with chronic alterations in cardiac energy metabolism in general and fatty acid 6.2. Cardiac hypertrophy utilization in particular [2, [83] [84] [85] [86] [87] . Although detailed biochemical investigations have shown that some types of During the past decade experimental and clinical evicardiomyopathies are related to malfunctioning of enzymes dence has been provided that fuel selection is considerably involved in cardiac fatty acid metabolism [88] [89] [90] [91] , recent altered in the hypertrophying heart [2, 84] . The striking findings suggest that proteins putatively involved in fatty decline in myocardial fatty acid oxidation with a concomiacid uptake and transport may also play a role in cardiac tant enhancement of glucose utilization strongly suggests abnormalities. Below, two pathological conditions, i.e., that energy metabolism in the hypertrophied heart switches diabetes and cardiac hypertrophy, will be discussed.
to the fetal programme [103] . The decline in fatty acid oxidation was found to be due to the hypertrophic con-6.1. Diabetic heart dition per se rather than alterations in blood pressure and / or plasma concentration of fatty acids [104, 105] . The In the diabetic heart fuel selection is appreciably observation that the oxidation rate of the medium-chain changed, but the direction and magnitude of changes in fatty acid octanoate did not differ between hypertrophied glucose and fatty acid utilization appear to differ among and control hearts indicates a crucial role of carnitinevarious species and to be experimental model dependent. It dependent processes in the decline of fatty acid utilization is of interest to note that similar model dependency is also in the hypertrophied heart [106] . This finding may also reported for the sensitivity of the diabetic heart towards point to the importance of protein-mediated transport ischemic injury [92] . In rats rendered diabetic by strepprocesses since the solubility of octanoate is appreciably tozotocin-treatment glucose oxidation is severely depressed higher than that of long-chain fatty acids. and fatty acid oxidation enhanced [85, 93] . This condition
The mechanism responsible for the switch from fatty is found to be associated with increased levels of cytoacid to glucose metabolism in the hypertrophied heart plasmic FABP [94] [95] [96] and mRNA and protein levels of might be pluriform. Alterations in, for instance, the cellular FAT / CD36 [97, 98] . Heyliger et al. [99] provided circumconcentration of cofactors or the degree of phosphorylation stantial evidence that in the diabetic rat heart proteinof enzymes have to be taken into consideration. In this mediated binding of fatty acids to the sarcolemma is respect the reported decline in myocardial carnitine content elevated. Studies conducted on diabetic mice revealed in animal models of cardiac hypertrophy and failure substantially increased FAT / CD36 levels in cardiac endo- [107, 108] and in patients with end-stage heart failure [109, 110] are worth mentioning. Alternatively, the switch prolongation, but normal cardiac perfusion, suggests the in fuel selection may be caused by alterations in gene involvement of a hereditary myocardial metabolic abnorexpression [2, 111] . In a rat model with progressive left mality. It remains to be established, however, whether this ventricular hypertrophy mRNA levels of a number of abnormality is caused by disruption of genes involved in enzymes of the b-oxidative pathway were found to be cardiac fatty acid uptake and transport. coordinately downregulated during compensated hypertrophy and cardiac failure, while similar changes were observed in the failing human heart [111] . Animal studies 7. Regulation of genes involved in cardiac fatty acid showed that in the hypertrophied heart of spontaneously handling hypertensive rats the cytoplasmic FABP content is slightly, but significantly decreased [112] . Unfortunately, no inAs described above various lines of evidence suggest formation is yet available on the tissue contents of that chronic alterations in the cardiac utilization of fatty membrane fatty acid-binding proteins such as FAT, FATP acids can be attributed to adjustments of the expression of or FABP in the compensated or failing hypertrophied genes involved in uptake, transport and metabolic converpm heart. sion of fatty acids. So far the mechanisms involved remain It is of interest to note that in addition to pressure to be elucidated. On the basis of experimental observations overload direct interventions in cardiac fatty acid handling in parenchymal cells, such as adipocytes and hepatocytes, eventually entail myocardial hypertrophy. Chronic inhibiit can be concluded that substrates for cellular energy tion of carnitine acyl transferase I by POCA resulted in a conversion themselves are capable of controlling transcripsignificantly increased left ventricular weight of the adult tional activity of metabolic genes [118] [119] [120] [121] . Both oxygen, rat [113] . More recently, Kusaka et al. [114] reported that and glucose and fatty acids or their derivatives are prolonged treatment of laboratory rats with sulfo-N-sucsupposed to influence the intracellular level of proteins cinimidyl palmitate, an effective blocker of FAT / CD36 involved in fuel selection and intermediary metabolism [2] . [67] , gives rise to a 12% increase in heart weight, Recent findings in cultured neonatal cardiomyocytes [10] compared to untreated controls. Moreover, spontaneously support the notion that exogenous fatty acids act also as hypertensive rats (SHR), the hearts of which are sigmodulators of cardiac transcriptional activity. When rat nificantly enlarged, appear to be defective in the FAT / neonatal cardiomyocytes are exposed to physiological CD36 gene [115] . Studies by Binas et al. [80] on H-FABP levels of fatty acids in the surrounding medium, the RNA knock out mice indicated the absence of this protein to transcripts of a set of cellular proteins, involved in fatty elicit the development of cardiac hypertrophy at the older acid uptake and mitochondrial catabolism, are appreciably age (.1 year). These findings are in favor of the notion increased compared to cells chronically exposed to glucose that in small rodents defects in carrier-mediated fatty acid in the absence of fatty acids (Fig. 4) . mRNA levels of uptake lead to impaired fatty acid utilization and altera-FAT / CD36, FABP, fatty acyl-CoA synthetase and longtions of the cardiac muscle cell phenotype.
chain acyl-CoA dehydrogenase all showed a 3-fold inClinical studies [11, 12] revealed in the Japanese populacrease [10, 122] . If one assumes that enhanced mRNAs are tion a high prevalence of a point mutation in the FAT / CD36 gene (48T→48C) resulting in FAT / CD36 deficiency. Patients, being homozygous for the 48T→48C substitution developed hypertrophic cardiomyopathy. These patients showed a complete lack of myocardial 123 extraction of the radiolabeled fatty acid analogue I-BMIPP from the vascular compartment. These findings are the first clinical evidence of a possible causal relationship between disruption of a gene encoding for a putative fatty acid transport protein and impaired cardiac function. Very recently, however, the notion of a causal relationship between FAT / CD36 deficiency and cardiac abnormalities in man has been challenged by Nakamura et al. [116] . They failed to disclose a significant difference in sci- associated with elevated protein levels, fatty acids or their different genes, the level of expression being cell type derivatives can control their own rate of utilization through dependent [131] [132] [133] [134] . PPARa is expressed in brain, kidfine-tuning of gene expression (in other words, fatty acids ney, liver, skeletal muscle and heart. PPARb shows an beget fatty acid utilization). Indeed, the capacity to oxidize ubiquitous expression pattern, while PPARg appears to be exogenous fatty acids is significantly increased in cultured more or less confined to fat cells [2] . The presence of both neonatal cardiomyocytes previously exposed to fatty acids PPARa and PPARb in cardiac muscle cells opens the in the incubation medium [122] . In this respect it is also of intriguing possibility that the interaction between these interest to note that during maturation a significant increase transcription factors and their potential ligands, i.e., longof cardiac fatty acid oxidation is observed, starting a chain fatty acids or their derivatives, helps to control the couple of days after birth [84, 123, 124] , most likely due to rate of gene transcription of proteins involved in fatty acid hormonal influences, although the effect of enhanced transport in this cell type. Further experiments are required circulating levels of fatty acids cannot be excluded. The to obtain a complete view on this important aspect of maturational increase in cardiac fatty acid oxidation was cardiac fatty acid uptake and metabolism. found to be associated with appreciably increased tissue contents of putative fatty acid transport proteins, such as FAT / CD36, FATP, and of cytoplasmic FABP [47, 125] .
8. Summary and future directions The observation that chronic administration of fatty acids to cultured neonatal cardiomyocytes results in tranCircumstantial evidence is accumulating that proteins scriptional upregulation of a set of fatty acid handling are involved in the uptake and intracardiac transport of genes, implies that the cells are capable of sensing changes long-chain fatty acids. In addition to cytoplasmic fatty in the supply of fatty acids (or fatty acid derivatives).
acid-binding protein (heart-type FABP), a set of memAlthough precise information about the mechanism underbrane-associated proteins (FABP , FAT / CD36, FATP) pm lying fatty acid sensing in cardiac cells is lacking, it is has been identified that might facilitate transfer of fatty tempting to speculate that intracellular proteins that bind acids across both endothelial and muscular cell memfatty acids or fatty acyl derivatives are involved. Both branes, as additional mechanism to passive diffusion. FABP and acylCoA-binding protein have been postulated
Recent findings indicate that expression of fatty acid to confer fatty acids to the fatty acid sensing machinery handling proteins in cardiac cells is controlled (at least in [9] . Evidence for a crucial role of the former protein in part) by fatty acids themselves. Further experiments are fatty acid modulated gene expression in the heart is, required to fully understand the molecular mechanisms however, poor, since a recently generated heart-type FABP underlying cardiac fatty acid-sensing and transcriptional knock-out mouse did not show major phenotypic alteracontrol of genes encoding for fatty acid-binding and / or tions up to 14 months after birth, apart from a 50% transporting proteins. reduction in cardiac fatty acid oxidation, suggesting that Involvement of proteins in fatty acid handling by the this protein does not play a crucial role in fatty acid heart might have clinical ramifications. Alterations in the mediated signal transduction [80] . cellular content or intracellular localization of proteins It is of interest to note that within the promoter region of (putatively) involved in fatty acid uptake and transport lipoprotein lipase, FATP as well as FAT / CD36 cis-regulamay compromise cardiac function. Conversely, cardiac tory elements are present which contain binding sites for diseases may lead to alterations in the expression and / or specific hormone receptors [2, 103] . Sophisticated moleculocalization of these fatty acid-handling proteins. Elucidalar biological techniques have revealed that proteins, such tion of the precise relationship between cardiac function as the transcription factors COUP/ TF, PPAR, RXR, HFNunder normal and pathological conditions, such as dia-4 and oestrogen-related receptor-a, interact with these betes, hypertrophy and pump failure on the one hand, and cis-regulatory elements [103, 126] . In particular, PPAR is a proteins involved in fatty acid uptake and transport on the likely candidate for cellular fatty acid sensing, as evidence
other, may open new avenues for sophisticated and is accumulating that fatty acids may act as natural ligands targeted interventions aiming at mitigating, preventing or of the PPARs [127] [128] [129] . The PPARs are well-equipped to restoring these cardiac abnormalities. act as general sensors of the lipid status, since they demonstrate limited specificity towards individual fatty acid species. Although subtle differences are apparent
